Biological screening of natural products and drug innovation in China

被引:91
作者
Wang, Ming-Wei
Hao, Xiaojiang
Chen, Kaixian
机构
[1] National Centre for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
[2] Kunming Institute of Botany, Chinese Academy of Sciences
关键词
natural products; traditional Chinese medicine; drug screening; high-throughput technologies; clinical trial; therapeutics;
D O I
10.1098/rstb.2007.2036
中图分类号
Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Natural products have been applied to human healthcare for thousands of years. Drug discovery in ancient times was largely by chance and based on clinical practices. As understanding of therapeutic benefits deepens and demands for natural products increase, previously serendipitous discoveries evolve into active searches for new medicines. Many drugs presently prescribed by physicians are either directly isolated from plants or are artificially modified versions of natural products. Scientists are looking for lead compounds with specific structures and pharmacological effects often from natural sources. Experiences and successes of Chinese scientists in this specialized area have resulted in a number of widely used drugs. The tremendous progress made in life sciences has not only revealed many pathological processes of diseases, but also led to the establishment of various molecular and cellular bioassays in conjunction with high-throughput technologies. This is advantageous and permits certain natural compounds that are difficult to isolate and purify, and compounds that are difficult to synthesize, to be assayed. The transition from traditional to empirical and to molecular screening will certainly increase the probability of discovering new leads and drug candidates from natural products.
引用
收藏
页码:1093 / 1105
页数:13
相关论文
共 93 条
[1]
A JY, 2003, EUR J DRUG METAB PH, V28, P265
[2]
A JY, 2002, ACTA PHARM SIN, V37, P283
[3]
Birdsall T. C., 1997, Alternative Medicine Review, V2, P94
[4]
BN 52021 AND RELATED-COMPOUNDS - A NEW SERIES OF HIGHLY SPECIFIC PAF-ACETHER RECEPTOR ANTAGONISTS [J].
BRAQUET, PG .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (03) :384-384
[5]
ARTEETHER, A NEW ANTIMALARIAL DRUG - SYNTHESIS AND ANTIMALARIAL PROPERTIES [J].
BROSSI, A ;
VENUGOPALAN, B ;
GERPE, LD ;
YEH, HJC ;
FLIPPENANDERSON, JL ;
BUCHS, P ;
LUO, XD ;
MILHOUS, W ;
PETERS, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (03) :645-650
[6]
A PALLADIUM-CATALYZED ROUTE TO HUPERZINE-A AND ITS ANALOGS AND THEIR ANTICHOLINESTERASE ACTIVITY [J].
CAMPIANI, G ;
SUN, LQ ;
KOZIKOWSKI, AP ;
AAGAARD, P ;
MCKINNEY, M .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (27) :7660-7669
[7]
Chen JZ, 1998, BIOORG MED CHEM LETT, V8, P1291
[8]
Natural PTP1B inhibitors from Broussonetia papyrifera [J].
Chen, RM ;
Hu, LH ;
An, TY ;
Li, J ;
Shen, Q .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) :3387-3390
[9]
Chen Yongqin, 1998, Yaoxue Xuebao, V33, P132
[10]
BIOCHEMICAL EFFECTS OF BERBERINE [J].
CREASEY, WA .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (07) :1081-1084